Ghrelin - A key pleiotropic hormone-regulating systemic energy metabolism

Endocrine Development

Volumn 25, Issue , 2013, Pages 91-100

  Müller, Timo D ^a   Tschöp, Matthias H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE;

ANOREXIA NERVOSA; ARTICLE; BODY WEIGHT; CACHEXIA; CHEMICAL MODIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; ENDOCRINE FUNCTION; ENDOTHELIUM CELL; ENERGY METABOLISM; FAT INTAKE; FOOD INTAKE; GLUCOSE METABOLISM; HEART FAILURE; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; KIDNEY FAILURE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH MOTILITY; TUMOR GROWTH; WEIGHT GAIN; WILD TYPE; BODY FAT; ENERGY EXPENDITURE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CACHEXIA; EATING; EATING DISORDERS; ENERGY METABOLISM; GHRELIN; HUMANS; LIGANDS; MODELS, BIOLOGICAL; RECEPTORS, GHRELIN; WASTING SYNDROME;

EID: 84925862257     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000346590     Document Type: Article

References (104)

1. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, et al: Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 1980; 106: 663-667.
2. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, et al: Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology 1981; 108:31-39.
3. Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, et al: Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997; 18: 621-645.
4. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, et al: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273:974-977.
5. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, et al: Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48:23-29.
6. Willesen MG, Kristensen P, Romer J: Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neu-roendocrinology 1999; 70:306-316.
7. Dickson SL, Luckman SM: Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997; 138:771-777.
8. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al: Ghrelin is a growth-hormone-releasing acyl-ated peptide from stomach. Nature 1999; 402:656-660.
9. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000; 407:908-913.
10. Kojima M, Kangawa K: Structure and function of ghrelin. Results Probl Cell Differ 2008; 46:89-115.
11. van der Lely AJ, Tschop M, Heiman ML, Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25:426-457.
12. Sakata I, Nakamura K, Yamazaki M, Matsubara M, Hayashi Y, et al: Ghrelin-producing cells exist as two types of cells, closed-and opened-type cells, in the rat gastrointestinal tract. Peptides 2002; 23:531-536.
13. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, et al: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2002; 141:4255-4261.
14. Masuda T, Ohta M, Hirashita T, Kawano Y, Eguchi H, et al: A comparative study of gastric banding and sleeve gastrectomy in an obese diabetic rat model. Obes Surg 2011; 21:1774-1780.
15. Cummings BP, Bettaieb A, Graham JL, Stanhope KL, Kowala M, et al: Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats. Endocrinology 2012; 153:3620-3632.
16. Yan L, Zhu Z, Wu D, Zhou Q, Wu Y: Effects of sleeve gastrectomy surgery with modified jejunoileal bypass on body weight, food intake and metabolic hormone levels of rats. J Huazhong Univ Sci Technolog Med Sci 2011; 31:784-788.
17. Wang Y, Yan L, Jin Z, Xin X: Effects of sleeve gastrec-tomy in neonatally streptozotocin-induced diabetic rats. PLoS One 2011; 6:e16383.
18. Li F, Zhang G, Liang J, Ding X, Cheng Z, et al: Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats. J Gastrointest Surg 2009; 13:2302-2308.
19. Wang Y, Liu J: Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes Surg 2009; 19:357-362.
20. Leonetti F, Silecchia G, Iacobellis G, Ribaudo MC, Zappaterreno A, et al: Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endo-crinol Metab 2003; 88:4227-4231.
21. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, et al: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghre-lin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86:4753-4758.
22. Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, Gfrerer L, Ludvik B, et al: Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 2010; 20:535-540.
23. Goitein D, Lederfein D, Tzioni R, Berkenstadt H, Venturero M, et al: Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients-a possible guide for efficient sleeve gastrectomy construction. Obes Surg 2012; 22:617-622.
24. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK: Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and pep-tide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247:401-407.
25. Langer FB, Reza Hoda MA, Bohdjalian A, Felber-bauer FX, Zacherl J, et al: Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15:1024-1029.
26. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, et al: Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 2012; 22:740-748.
27. Ramon JM, Salvans S, Crous X, Puig S, Goday A, et al: Effect of Roux-en-Y gastric bypass vs. sleeve gas-trectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg 2012; 16: 1116-1122.
28. Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, et al: Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2011; 7:683-690.
29. Basso N, Capoccia D, Rizzello M, Abbatini F, Mari-ani P, et al: First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 2011; 25:3540-3550.
30. Korbonits M, Kojima M, Kangawa K, Grossman AB: Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 2001; 14:101-104.
31. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, et al: The expression of the growth hormone se-cretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001; 86:881-887.
32. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L: Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci USA 2004; 101:2924-2929.
33. Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S: Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009; 41:814-821.
34. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, et al: Expression of ghrelin and of the GH secreta-gogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002; 87: 1300-1308.
35. Volante M, Allia E, Fulcheri E, Cassoni P, Ghigo E, et al: Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol 2003; 162:645-654.
36. Volante M, Fulcheri E, Allia E, Cerrato M, Pucci A, et al: Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 2002; 50:1013-1021.
37. Cowley MA, Smith RG, Diano S, Tschop M, Pron-chuk N, et al: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37:649-661.
38. Hou Z, Miao Y, Gao L, Pan H, Zhu S: Ghrelin-con-taining neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul Pept 2006; 134:126-131.
39. Brinckerhoff TZ, Bondada S, Lewis CE, French SW, Deugarte DA: Metabolic effects of sleeve gastrecto-my in female rat model of diet-induced obesity. Surg Obes Relat Dis 2011.
40. Patrikakos P, Toutouzas KG, Gazouli M, Perrea D, Menenakos E, et al: Long-term plasma ghrelin and leptin modulation after sleeve gastrectomy in Wistar rats in comparison with gastric tissue ghrelin expression. Obes Surg 2011; 21:1432-1437.
41. Lopez PP, Nicholson SE, Burkhardt GE, Johnson RA, Johnson FK: Development of a sleeve gastrec-tomy weight loss model in obese Zucker rats. J Surg Res 2009; 157:243-250.
42. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, et al: Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105:6320-6325.
43. Yang J, Zhao TJ, Goldstein JL, Brown MS: Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylat-ed pentapeptides. Proc Natl Acad Sci USA 2008; 105: 10750-10755.
44. Sakata I, Yang J, Lee CE, Osborne-Lawrence S, Rovin-sky SA, et al: Colocalization of ghrelin O-acyltransfer-ase and ghrelin in gastric mucosal cells. Am J Physiol Endocrinol Metab 2009; 297:E134-E141.
45. Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, et al: Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007; 18:986-994.
46. Li L, Zhang LK, Pang YZ, Pan CS, Qi YF, et al: Car-dioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproter-enol in rats. Acta Pharmacol Sin 2006; 27:527-535.
47. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, et al: Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159:1029-1037.
48. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, et al: Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone se-cretagogue receptor. Endocrinology 2004; 145:234-242.
49. Toshinai K, Yamaguchi H, Sun Y, Smith RG, Ya-manaka A, et al: Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006; 147:2306-2314.
50. Zhang W, Chai B, Li JY, Wang H, Mulholland MW: Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008; 149:4710-4716.
51. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, et al: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50:1714-1719.
52. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidling-maier M, et al: Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001; 24:RC19-RC21.
53. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, et al: Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002; 56:203-206.
54. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, et al: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87:240-244.
55. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, et al: Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50:707-709.
56. Nakai Y, Hosoda H, Nin K, Ooya C, Hayashi H, et al: Short-term secretory regulation of the active form of ghrelin and total ghrelin during an oral glucose tolerance test in patients with anorexia nervosa. Eur J En-docrinol 2004; 150:913-914.
57. Tolle V, Kadem M, Bluet-Pajot MT, Frere D, Foulon C, et al: Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003; 88:109-116.
58. Harada T, Nakahara T, Yasuhara D, Kojima S, Sagi-yama K, et al: Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry 2008; 63:245-247.
59. Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M, et al: Elevated circulating level of ghrelin in ca-chexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001; 104:2034-2038.
60. Xin X, Ren AJ, Zheng X, Qin YW, Zhao XX, et al: Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia. Peptides 2009; 30:2281-2285.
61. Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, et al: Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13:2748-2752.
62. Aygen B, Dogukan A, Dursun FE, Aydin S, Kilic N, et al: Ghrelin and obestatin levels in end-stage renal disease. J Int Med Res 2009; 37:757-765.
63. Lainscak M, Andreas S, Scanlon PD, Somers VK, Anker SD: Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopul-monary disease. Intern Med 2006; 45:837.
64. Itoh T, Nagaya N, Yoshikawa M, Fukuoka A, Take-naka H, et al: Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:879-882.
65. Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, et al: Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003; 9:774-778.
66. Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, et al: Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin En-docrinol Metab 2005; 90:2920-2926.
67. Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, et al: Adiponectin, ghrelin, and leptin in cancer ca-chexia in breast and colon cancer patients. Cancer 2006; 106:966-973.
68. Williams DL, Cummings DE: Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 2005; 135:1320-1325.
69. Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, et al: GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009; 15:741-745.
70. Perez-Tilve D, Heppner K, Kirchner H, Lockie SH, Woods SC, et al: Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J 2011; 25: 2814-2822.
71. Barsh GS, Schwartz MW: Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 2002; 3:589-600.
72. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, et al: Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000; 141: 4797-4800.
73. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, et al: Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001; 50:2438-2443.
74. Nakazato M, Murakami N, Date Y, Kojima M, Mat-suo H, et al: A role for ghrelin in the central regulation of feeding. Nature 2001; 409:194-198.
75. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, et al: Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006; 116:1983-1993.
76. von Haehling S, Lainscak M, Springer J, Anker SD: Cardiac cachexia: a systematic overview. Pharmacol Ther 2009; 121:227-252.
77. Ashby D, Choi P, Bloom S: Gut hormones and the treatment of disease cachexia. Proc Nutr Soc 2008; 67:263-269.
78. Muller TD, Perez-Tilve D, Tong J, Pfluger PT, Tschop MH: Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia. J Ca-chexia Sarcopenia Muscle 2010; 1:159-167.
79. Ashitani J, Matsumoto N, Nakazato M: Ghrelin and its therapeutic potential for cachectic patients. Pep-tides 2009; 30:1951-1956.
80. Langhans W: Peripheral mechanisms involved with catabolism. Curr Opin Clin Nutr Metab Care 2002; 5:419-426.
81. Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B: The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry 2007; 12:23-35.
82. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, et al: Weight gain decreases elevated plasma ghre-lin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001; 145:669-673.
83. Otto B, Tschop M, Fruhauf E, Heldwein W, Fichter M, et al: Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroen-docrinology 2005; 30:577-581.
84. Haas V, Onur S, Paul T, Nutzinger DO, Bosy-West-phal A, et al: Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am J Clin Nutr 2005; 81:889-896.
85. Germain N, Galusca B, Grouselle D, Frere D, Tolle V, et al: Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa. Psychoneuroendocrinology 2009; 34:413-419.
86. Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, et al: Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) 2009; 29: 1130-1136.
87. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, et al: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
88. Garcia JM, Polvino WJ: Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 2007; 12:594-600.
89. Hotta M, Ohwada R, Akamizu T, Shibasaki T, Takano K, et al: Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr J 2009; 56:1119-1128.
90. Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW: Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 1997; 156:1800-1806.
91. Nagaya N, Kangawa K: Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regul Pept 2003; 114:71-77.
92. Nagaya N, Kangawa K: Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 2003; 3:146-151.
93. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshi-hara F, et al: Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104:1430-1435.
94. Xu XB, Pang JJ, Cao JM, Ni C, Xu RK, et al: GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. Am J Physiol Heart Circ Physiol 2005; 289:H1643-H1651.
95. Deboer MD, Zhu X, Levasseur PR, Inui A, Hu Z, et al: Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 2008; 149:827-835.
96. Hanada T, Toshinai K, Kajimura N, Nara-Ashizawa N, Tsukada T, et al: Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Bio-chem Biophys Res Commun 2003; 301:275-279.
97. Hanada T, Toshinai K, Date Y, Kajimura N, Tsu-kada T, et al: Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells. Metabolism 2004; 53:84-88.
98. DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, et al: Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007; 148: 3004-3012.
99. Wynne K, Giannitsopoulou K, Small CJ, Patterson M, Frost G, et al: Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005; 16:2111-2118.
100. Ashby DR, Ford HE, Wynne KJ, Wren AM, Murphy KG, et al: Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009; 76:199-206.
101. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, et al: Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004; 110:3674-3679.
102. Nagaya N, Itoh T, Murakami S, Oya H, Uematsu M, et al: Treatment of cachexia with ghrelin in patients with COPD. Chest 2005; 128:1187-1193.
103. Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, et al: Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004; 89:2832-2836.
104. Strasser F, Lutz TA, Maeder MT, Thuerlimann B, Bueche D, et al: Safety, tolerability and pharmacoki-netics of intravenous ghrelin for cancer-related an-orexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 2008; 98:300-308.